Sesamin
CAS 607-80-7
Sesamin (CAS 607-80-7) is a pharmaceutical compound with 5 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 25725.420000000002 nM | 10 | - |
| - | IC50 | 47916.524 nM | 4 | - |
| - | IC50 | 2.84 ug.mL-1 | 2 | - |
| - | EC50 | 60000 nM | 1 | - |
| - | MIC | 200 ug.mL-1 | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| CYP4F2 CYP4F2 |
Inhibition | 6.420000076293945 pIC50 | 32238710 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Sesamin used for in pharmaceutical contexts?
Sesamin (CAS 607-80-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Sesamin?
No adverse-event association or SIDER side-effect rows are rendered for Sesamin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Sesamin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Sesamin with EU status "permitted".
What clinical phase is Sesamin in?
No phase 1-4 clinical development badge is rendered for Sesamin because the matched compound identifier rows do not contain a max-phase value.